Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
Jennifer P. Habashi,1*
Daniel P. Judge,2*
Tammy M. Holm,1
Ronald D. Cohn,1
Bart L. Loeys,1
Timothy K. Cooper,1,3
Loretha Myers,1
Erin C. Klein,1
Guosheng Liu,3
Carla Calvi,2
Megan Podowski,2
Enid R. Neptune,2
Marc K. Halushka,4
Djahida Bedja,3
Kathleen Gabrielson,3
Daniel B. Rifkin,5
Luca Carta,6
Francesco Ramirez,6
David L. Huso,3
Harry C. Dietz1,2
Abstract:
Aortic aneurysm and dissection are manifestations of Marfansyndrome (MFS), a disorder caused by mutations in the gene thatencodes fibrillin-1. Selected manifestations of MFS reflectexcessive signaling by the transforming growth factor–ß(TGF-ß) family of cytokines. We show that aortic aneurysmin a mouse model of MFS is associated with increased TGF-ßsignaling and can be prevented by TGF-ß antagonistssuch as TGF-ß–neutralizing antibody or the angiotensinII type 1 receptor (AT1) blocker, losartan. AT1 antagonism alsopartially reversed noncardiovascular manifestations of MFS,including impaired alveolar septation. These data suggest thatlosartan, a drug already in clinical use for hypertension, meritsinvestigation as a therapeutic strategy for patients with MFSand has the potential to prevent the major life-threateningmanifestation of this disorder.
1 Howard Hughes Medical Institute and Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. 2 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. 3 Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. 4 Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. 5 Departments of Cell Biology and Medicine, New York University School of Medicine, New York, NY 10016, USA. 6 Child Health Institute of New Jersey, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, New Brunswick, NJ 08903, USA.
* These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail: hdietz{at}jhmi.edu
The editors suggest the following Related Resources on Science sites:
Angiotensin-Converting Enzyme-Induced Activation of Local Angiotensin Signaling Is Required for Ascending Aortic Aneurysms in Fibulin-4-Deficient Mice.
J. Huang, Y. Yamashiro, C. L. Papke, Y. Ikeda, Y. Lin, M. Patel, T. Inagami, V. P. Le, J. E. Wagenseil, and H. Yanagisawa (2013)
Science Translational Medicine
5, 183ra58
|Abstract »|Full Text »|PDF »
SMAD1 Deficiency in Either Endothelial or Smooth Muscle Cells Can Predispose Mice to Pulmonary Hypertension.
C. Han, K.-H. Hong, Y. H. Kim, M.-J. Kim, C. Song, M. J. Kim, S.-J. Kim, M. K. Raizada, and S. P. Oh (2013)
Hypertension
61, 1044-1052
|Abstract »|Full Text »|PDF »
The Role of TGF-{beta} in Polycystic Ovary Syndrome.
N. Raja-Khan, M. Urbanek, R. J. Rodgers, and R. S. Legro (2013)
Reproductive Sciences
|Abstract »|Full Text »|PDF »
Medical management of thoracic aortic aneurysm disease.
Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
G. Guo, B. Munoz-Garcia, C.-E. Ott, J. Grunhagen, S. A. Mousa, A. Pletschacher, Y. von Kodolitsch, P. Knaus, and P. N. Robinson (2013)
Hum. Mol. Genet.
22, 433-443
|Abstract »|Full Text »|PDF »
Reply: Beneficial Effects of Angiotensin Receptor Blockade in Chronic Obstructive Pulmonary Disease.
D. D. Sin, S. Van Eeden, J. Leipsic, and S. F. P. Man (2013) 187, 328
|Full Text »|PDF »
The fibrillin-1 gene: unlocking new therapeutic pathways in cardiovascular disease.
Late complications and distal growth rates of Marfan aortas after proximal aortic repair.
F. A. Kari, M. F. Russe, P. Peter, P. Blanke, B. Rylski, W. Euringer, F. Beyersdorf, and M. Siepe (2013)
Eur J Cardiothorac Surg
|Abstract »|Full Text »|PDF »
Effect of Angiotensin II Receptor Blocker on Experimental Periodontitis in a Mouse Model of Marfan Syndrome.
T. Kurihara, R. Shimizu-Hirota, M. Shimoda, T. Adachi, H. Shimizu, S. J. Weiss, H. Itoh, S. Hori, N. Aikawa, and Y. Okada (2012)
Circulation
126, 3070-3080
|Abstract »|Full Text »|PDF »
Aneurysm prevention: keep the cat out of the bag.
K. J. Rodgers and C. L. Jackson (2012)
Cardiovasc Res
96, 350-351
|Full Text »|PDF »
COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets.
D. S. Kuo, C. Labelle-Dumais, and D. B. Gould (2012)
Hum. Mol. Genet.
21, R97-R110
|Abstract »|Full Text »|PDF »
In Vivo Regulation of TGF-{beta} by R-Ras2 Revealed through Loss of the RasGAP Protein NF1.
D. M. Patmore, S. Welch, P. C. Fulkerson, J. Wu, K. Choi, D. Eaves, J. J. Kordich, M. H. Collins, T. P. Cripe, and N. Ratner (2012)
Cancer Res.
72, 5317-5327
|Abstract »|Full Text »|PDF »
Genetic Basis of Familial Valvular Heart Disease.
R. Padang, R. D. Bagnall, and C. Semsarian (2012)
Circ Cardiovasc Genet
5, 569-580
|Full Text »|PDF »
Cardiovascular findings and management in Turner syndrome: insights from a French cohort.
B. Donadille, A. Rousseau, D. Zenaty, S. Cabrol, C. Courtillot, D. Samara-Boustani, S. Salenave, L. Monnier-Cholley, C. Meuleman, G. Jondeau, et al. (2012)
Eur. J. Endocrinol.
167, 517-522
|Abstract »|Full Text »|PDF »
Cardiovascular Phenotype in Turner Syndrome--Integrating Cardiology, Genetics, and Endocrinology.
K. H. Mortensen, N. H. Andersen, and C. H. Gravholt (2012)
Endocr. Rev.
33, 677-714
|Abstract »|Full Text »|PDF »
Activation of the stress proteome as a mechanism for small molecule therapeutics.
R. D. Brose, G. Shin, M. C. McGuinness, T. Schneidereith, S. Purvis, G. X. Dong, J. Keefer, F. Spencer, and K. D. Smith (2012)
Hum. Mol. Genet.
21, 4237-4252
|Abstract »|Full Text »|PDF »
Matrix control of transforming growth factor-{beta} function.
Modulation of Transforming Growth Factor-{beta} Signaling and Extracellular Matrix Production in Myxomatous Mitral Valves by Angiotensin II Receptor Blockers.
A. Geirsson, M. Singh, R. Ali, H. Abbas, W. Li, J. A. Sanchez, S. Hashim, and G. Tellides (2012)
Circulation
126, S189-S197
|Abstract »|Full Text »|PDF »
Angiotensin-converting enzyme insertion/deletion polymorphism is a risk factor for thoracic aortic aneurysm in patients with bicuspid or tricuspid aortic valves.
I. Foffa, M. Murzi, M. Mariani, A. M. Mazzone, M. Glauber, L. Ait Ali, and M. G. Andreassi (2012)
J. Thorac. Cardiovasc. Surg.
144, 390-395
|Abstract »|Full Text »|PDF »
MMP-2 Regulates Erk1/2 Phosphorylation and Aortic Dilatation in Marfan Syndrome.
W. Xiong, T. Meisinger, R. Knispel, J. M. Worth, and B. T. Baxter (2012)
Circ. Res.
110, e92-e101
|Abstract »|Full Text »|PDF »
20.2 Inherited defects of connective tissue: Ehlers-Danlos syndrome, Marfan's syndrome, and pseudoxanthoma elasticum.
Transient Exposure of Neonatal Female Mice to Testosterone Abrogates the Sexual Dimorphism of Abdominal Aortic Aneurysms.
X. Zhang, S. E. Thatcher, D. L. Rateri, D. Bruemmer, R. Charnigo, A. Daugherty, and L. A. Cassis (2012)
Circ. Res.
110, e73-e85
|Abstract »|Full Text »|PDF »
Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-{beta} signaling.
H. Wei, D. Bedja, N. Koitabashi, D. Xing, J. Chen, K. Fox-Talbot, R. Rouf, S. Chen, C. Steenbergen, J. W. Harmon, et al. (2012)
PNAS
109, E841-E850
|Abstract »|Full Text »|PDF »
GLUT10 is required for the development of the cardiovascular system and the notochord and connects mitochondrial function to TGF{beta} signaling.
A. Willaert, S. Khatri, B. L. Callewaert, P. J. Coucke, S. D. Crosby, J. G. H. Lee, E. C. Davis, S. Shiva, M. Tsang, A. De Paepe, et al. (2012)
Hum. Mol. Genet.
21, 1248-1259
|Abstract »|Full Text »|PDF »
Interplay Between Heart and Skeletal Muscle Disease in Heart Failure: The 2011 George E. Brown Memorial Lecture.
Can early aortic root surgery prevent further aortic dissection in Marfan syndrome?.
H. Shimizu, H. Kasahara, A. Nemoto, K. Yamabe, T. Ueda, and R. Yozu (2012)
Interact CardioVasc Thorac Surg
14, 171-175
|Abstract »|Full Text »|PDF »
ADAMTSL4, a Secreted Glycoprotein Widely Distributed in the Eye, Binds Fibrillin-1 Microfibrils and Accelerates Microfibril Biogenesis.
L. A. R. Gabriel, L. W. Wang, H. Bader, J. C. Ho, A. K. Majors, J. G. Hollyfield, E. I. Traboulsi, and S. S. Apte (2012)
Invest. Ophthalmol. Vis. Sci.
53, 461-469
|Abstract »|Full Text »|PDF »
Fibroblast Growth Factor 9 (FGF9)-Pituitary Homeobox 2 (PITX2) Pathway Mediates Transforming Growth Factor {beta} (TGF{beta}) Signaling to Regulate Cell Proliferation in Palatal Mesenchyme during Mouse Palatogenesis.
J.-i. Iwata, L. Tung, M. Urata, J. G. Hacia, R. Pelikan, A. Suzuki, L. Ramenzoni, O. Chaudhry, C. Parada, P. A. Sanchez-Lara, et al. (2012)
J. Biol. Chem.
287, 2353-2363
|Abstract »|Full Text »|PDF »
miR-29b Participates in Early Aneurysm Development in Marfan Syndrome.
D. R. Merk, J. T. Chin, B. A. Dake, L. Maegdefessel, M. O. Miller, N. Kimura, P. S. Tsao, C. Iosef, G. J. Berry, F. W. Mohr, et al. (2012)
Circ. Res.
110, 312-324
|Abstract »|Full Text »|PDF »
Skeletogenic phenotype of human Marfan embryonic stem cells faithfully phenocopied by patient-specific induced-pluripotent stem cells.
N. Quarto, B. Leonard, S. Li, M. Marchand, E. Anderson, B. Behr, U. Francke, R. Reijo-Pera, E. Chiao, and M. T. Longaker (2012)
PNAS
109, 215-220
|Abstract »|Full Text »|PDF »
Transforming Growth Factor-{beta} Signaling in Myogenic Cells Regulates Vascular Morphogenesis, Differentiation, and Matrix Synthesis.
M. Jaffe, C. Sesti, I. M. Washington, L. Du, N. Dronadula, M. T. Chin, D. B. Stolz, E. C. Davis, and D. A. Dichek (2012)
Arterioscler Thromb Vasc Biol
32, e1-e11
|Abstract »|Full Text »|PDF »
Mast cells are required for the development of renal fibrosis in the rodent unilateral ureteral obstruction model.
A. Veerappan, A. C. Reid, N. O'Connor, R. Mora, J. A. Brazin, R. Estephan, T. Kameue, J. Chen, D. Felsen, S. V. Seshan, et al. (2012)
Am J Physiol Renal Physiol
302, F192-F204
|Abstract »|Full Text »|PDF »
Genetic Modifiers of Cardiovascular Phenotype Caused by Elastin Haploinsufficiency Act by Extrinsic Noncomplementation.
B. A. Kozel, R. H. Knutsen, L. Ye, C. H. Ciliberto, T. J. Broekelmann, and R. P. Mecham (2011)
J. Biol. Chem.
286, 44926-44936
|Abstract »|Full Text »|PDF »
ADAMTSL6{beta} Protein Rescues Fibrillin-1 Microfibril Disorder in a Marfan Syndrome Mouse Model through the Promotion of Fibrillin-1 Assembly.
M. Saito, M. Kurokawa, M. Oda, M. Oshima, K. Tsutsui, K. Kosaka, K. Nakao, M. Ogawa, R.-i. Manabe, N. Suda, et al. (2011)
J. Biol. Chem.
286, 38602-38613
|Abstract »|Full Text »|PDF »
Cross Talk among TGF-{beta} Signaling Pathways, Integrins, and the Extracellular Matrix.
J. S. Munger and D. Sheppard (2011)
Cold Spring Harb Perspect Biol
3, a005017
|Abstract »|Full Text »|PDF »
Medical Therapy of Thoracic Aortic Aneurysms: Are We There Yet?.
P. Danyi, J. A. Elefteriades, and I. S. Jovin (2011)
Circulation
124, 1469-1476
|Full Text »|PDF »
Pravastatin Reduces Marfan Aortic Dilation.
D. McLoughlin, J. McGuinness, J. Byrne, E. Terzo, V. Huuskonen, H. McAllister, A. Black, S. Kearney, E. Kay, A. D. K. Hill, et al. (2011)
Circulation
124, S168-S173
|Abstract »|Full Text »|PDF »
Aortic Aneurysm Generation in Mice With Targeted Deletion of Integrin-Linked Kinase in Vascular Smooth Muscle Cells.
D. Shen, J. Li, J. J. Lepore, T. J. T. Anderson, S. Sinha, A. Y. Lin, L. Cheng, E. D. Cohen, J. D. Roberts Jr, S. Dedhar, et al. (2011)
Circ. Res.
109, 616-628
|Abstract »|Full Text »|PDF »
Increased Vertebral Artery Tortuosity Index Is Associated With Adverse Outcomes in Children and Young Adults With Connective Tissue Disorders.
S. A. Morris, D. B. Orbach, T. Geva, M. N. Singh, K. Gauvreau, and R. V. Lacro (2011)
Circulation
124, 388-396
|Abstract »|Full Text »|PDF »
ADAMTS10 Protein Interacts with Fibrillin-1 and Promotes Its Deposition in Extracellular Matrix of Cultured Fibroblasts.
W. E. Kutz, L. W. Wang, H. L. Bader, A. K. Majors, K. Iwata, E. I. Traboulsi, L. Y. Sakai, D. R. Keene, and S. S. Apte (2011)
J. Biol. Chem.
286, 17156-17167
|Abstract »|Full Text »|PDF »
Noncanonical TGF{beta} Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice.
T. M. Holm, J. P. Habashi, J. J. Doyle, D. Bedja, Y. Chen, C. van Erp, M. E. Lindsay, D. Kim, F. Schoenhoff, R. D. Cohn, et al. (2011)
Science
332, 358-361
|Abstract »|Full Text »|PDF »
Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism.
J. P. Habashi, J. J. Doyle, T. M. Holm, H. Aziz, F. Schoenhoff, D. Bedja, Y. Chen, A. N. Modiri, D. P. Judge, and H. C. Dietz (2011)
Science
332, 361-365
|Abstract »|Full Text »|PDF »
Drosophila Mmp2 Regulates the Matrix Molecule Faulty Attraction (Frac) to Promote Motor Axon Targeting in Drosophila.
C. M. Miller, N. Liu, A. Page-McCaw, and H. T. Broihier (2011)
J. Neurosci.
31, 5335-5347
|Abstract »|Full Text »|PDF »
Parsing Aortic Aneurysms: More Surprises.
M. W. Majesky, X. R. Dong, and V. J. Hoglund (2011)
Circ. Res.
108, 528-530
|Full Text »|PDF »
Endothelial Cell-Specific Deficiency of Ang II Type 1a Receptors Attenuates Ang II-Induced Ascending Aortic Aneurysms in LDL Receptor-/- Mice.
D. L. Rateri, J. J. Moorleghen, A. Balakrishnan, A. P. Owens III, D. A. Howatt, V. Subramanian, A. Poduri, R. Charnigo, L. A. Cassis, and A. Daugherty (2011)
Circ. Res.
108, 574-581
|Abstract »|Full Text »|PDF »
Losartan Decreases Cardiac Muscle Fibrosis and Improves Cardiac Function in Dystrophin-Deficient Mdx Mice.
C. F. Spurney, A. Sali, A. D. Guerron, M. Iantorno, Q. Yu, H. Gordish-Dressman, S. Rayavarapu, J. van der Meulen, E. P. Hoffman, and K. Nagaraju (2011)
Journal of Cardiovascular Pharmacology and Therapeutics
16, 87-95
|Abstract »|PDF »
Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors.
B. Diop-Frimpong, V. P. Chauhan, S. Krane, Y. Boucher, and R. K. Jain (2011)
PNAS
108, 2909-2914
|Abstract »|Full Text »|PDF »
Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms.
D. Gomez, A. Coyet, V. Ollivier, X. Jeunemaitre, G. Jondeau, J.-B. Michel, and R. Vranckx (2011)
Cardiovasc Res
89, 446-456
|Abstract »|Full Text »|PDF »
Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome.
H. Nistala, S. Lee-Arteaga, L. Carta, J. R. Cook, S. Smaldone, G. Siciliano, A. N. Rifkin, H. C. Dietz, D. B. Rifkin, and F. Ramirez (2010)
Hum. Mol. Genet.
19, 4790-4798
|Abstract »|Full Text »|PDF »
Quantitative analysis of TGFBR2 mutations in Marfan-syndrome-related disorders suggests a correlation between phenotypic severity and Smad signaling activity.
D. Horbelt, G. Guo, P. N. Robinson, and P. Knaus (2010)
J. Cell Sci.
123, 4340-4350
|Abstract »|Full Text »|PDF »
Role of myofibroblasts in vascular remodelling: focus on restenosis and aneurysm.
A. Forte, A. Della Corte, M. De Feo, F. Cerasuolo, and M. Cipollaro (2010)
Cardiovasc Res
88, 395-405
|Abstract »|Full Text »|PDF »
The Haploinsufficient Col3a1 Mouse as a Model for Vascular Ehlers-Danlos Syndrome.
T. K. Cooper, Q. Zhong, M. Krawczyk, H.-J. Tae, G. A. Muller, R. Schubert, L. A. Myers, H. C. Dietz, M. I. Talan, and W. Briest (2010)
Veterinary Pathology
47, 1028-1039
|Abstract »|Full Text »|PDF »
Review Article: Genetics for the Pediatric Anesthesiologist: A Primer on Congenital Malformations, Pharmacogenetics, and Proteomics.
J. L. Galinkin, L. Demmer, and M. Yaster (2010)
Anesth. Analg.
111, 1264-1274
|Abstract »|Full Text »|PDF »
Extracellular Microfibrils Control Osteoblast-supported Osteoclastogenesis by Restricting TGF{beta} Stimulation of RANKL Production.
H. Nistala, S. Lee-Arteaga, S. Smaldone, G. Siciliano, and F. Ramirez (2010)
J. Biol. Chem.
285, 34126-34133
|Abstract »|Full Text »|PDF »
Cardiac pathologies in relation to Smad-dependent pathways.
Fibrillin-1 and -2 differentially modulate endogenous TGF-{beta} and BMP bioavailability during bone formation.
H. Nistala, S. Lee-Arteaga, S. Smaldone, G. Siciliano, L. Carta, R. N. Ono, G. Sengle, E. Arteaga-Solis, R. Levasseur, P. Ducy, et al. (2010)
J. Cell Biol.
190, 1107-1121
|Abstract »|Full Text »|PDF »
One step closer to personalized genomic medicine.
D. P. Judge (2010)
Eur. Heart J.
31, 2194-2196
|Full Text »|PDF »
Cardiovascular manifestations in men and women carrying a FBN1 mutation.
D. Detaint, L. Faivre, G. Collod-Beroud, A. H. Child, B. L. Loeys, C. Binquet, E. Gautier, E. Arbustini, K. Mayer, M. Arslan-Kirchner, et al. (2010)
Eur. Heart J.
31, 2223-2229
|Abstract »|Full Text »|PDF »
Multimodality Imaging Reveals a Gradual Increase in Matrix Metalloproteinase Activity at Aneurysmal Lesions in Live Fibulin-4 Mice.
E. L. Kaijzel, P. M. van Heijningen, P. A. Wielopolski, M. Vermeij, G. A. Koning, W. A. van Cappellen, I. Que, A. Chan, J. Dijkstra, N. W. M. Ramnath, et al. (2010)
Circ Cardiovasc Imaging
3, 567-577
|Abstract »|Full Text »|PDF »
In Vivo Studies of Mutant Fibrillin-1 Microfibrils.
N. L. Charbonneau, E. J. Carlson, S. Tufa, G. Sengle, E. C. Manalo, V. M. Carlberg, F. Ramirez, D. R. Keene, and L. Y. Sakai (2010)
J. Biol. Chem.
285, 24943-24955
|Abstract »|Full Text »|PDF »
Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome.
H. H. C. Yang, J. M. Kim, E. Chum, C. van Breemen, and A. W. Y. Chung (2010)
J. Thorac. Cardiovasc. Surg.
140, 305-312
|Abstract »|Full Text »|PDF »
Special Article: 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients with Thoracic Aortic Disease: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine.
WRITING COMMITTEE MEMBERS, L. F. Hiratzka, G. L. Bakris, J. A. Beckman, R. M. Bersin, V. F. Carr, D. E. Casey Jr, K. A. Eagle, L. K. Hermann, E. M. Isselbacher, et al. (2010)
Anesth. Analg.
111, 279-315
|Full Text »|PDF »
The revised Ghent nosology for the Marfan syndrome.
B. L. Loeys, H. C. Dietz, A. C. Braverman, B. L. Callewaert, J. De Backer, R. B. Devereux, Y. Hilhorst-Hofstee, G. Jondeau, L. Faivre, D. M. Milewicz, et al. (2010)
J. Med. Genet.
47, 476-485
|Abstract »|Full Text »|PDF »
Klf15 Deficiency Is a Molecular Link Between Heart Failure and Aortic Aneurysm Formation.
S. M. Haldar, Y. Lu, D. Jeyaraj, D. Kawanami, Y. Cui, S. J. Eapen, C. Hao, Y. Li, Y. Q. Doughman, M. Watanabe, et al. (2010)
Science Translational Medicine
2, 26ra26
|Abstract »|Full Text »|PDF »
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine.
WRITING GROUP MEMBERS, L. F. Hiratzka, G. L. Bakris, J. A. Beckman, R. M. Bersin, V. F. Carr, D. E. Casey Jr, K. A. Eagle, L. K. Hermann, E. M. Isselbacher, et al. (2010)
Circulation
121, e266-e369
|Full Text »|PDF »
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine.
WRITING COMMITTEE MEMBERS, L. F. Hiratzka, G. L. Bakris, J. A. Beckman, R. M. Bersin, V. F. Carr, D. E. Casey Jr, K. A. Eagle, L. K. Hermann, E. M. Isselbacher, et al. (2010)
Circulation
121, 1544-1579
|Full Text »|PDF »
Murine model of surgically induced acute aortic dissection type A.
P. Matt, D. L. Huso, J. Habashi, T. Holm, J. Doyle, F. Schoenhoff, G. Liu, J. Black, J. E. Van Eyk, and H. C. Dietz (2010)
J. Thorac. Cardiovasc. Surg.
139, 1041-1047
|Abstract »|Full Text »|PDF »
Mutations in Fibrillin-1 Cause Congenital Scleroderma: Stiff Skin Syndrome.
B. L. Loeys, E. E. Gerber, D. Riegert-Johnson, S. Iqbal, P. Whiteman, V. McConnell, C. R. Chillakuri, D. Macaya, P. J. Coucke, A. De Paepe, et al. (2010)
Science Translational Medicine
2, 23ra20
|Abstract »|Full Text »|PDF »
Small-molecule signal-transduction inhibitors: targeted therapeutic agents for single-gene disorders.
Angiotensin II Induces a Region-Specific Hyperplasia of the Ascending Aorta Through Regulation of Inhibitor of Differentiation 3.
A. P. Owens III, V. Subramanian, J. J. Moorleghen, Z. Guo, C. A. McNamara, L. A. Cassis, and A. Daugherty (2010)
Circ. Res.
106, 611-619
|Abstract »|Full Text »|PDF »
Atorvastatin Modulates Matrix Metalloproteinase Expression, Activity, and Signaling in Abdominal Aortic Aneurysms.
M. Schweitzer, B. Mitmaker, D. Obrand, N. Sheiner, C. Abraham, S. Dostanic, M. Meilleur, T. Sugahara, and L. E. Chalifour (2010)
Vascular and Endovascular Surgery
44, 116-122
|Abstract »|PDF »
S100A12 Mediates Aortic Wall Remodeling and Aortic Aneurysm.
M. Hofmann Bowman, J. Wilk, A. Heydemann, G. Kim, J. Rehman, J. A. Lodato, J. Raman, and E. M. McNally (2010)
Circ. Res.
106, 145-154
|Abstract »|Full Text »|PDF »
Smooth muscle phenotypic modulation is an early event in aortic aneurysms..
G. Ailawadi, C. W. Moehle, H. Pei, S. P. Walton, Z. Yang, I. L. Kron, C. L. Lau, and G. K. Owens (2009)
J. Thorac. Cardiovasc. Surg.
138, 1392-1399
|Abstract »|Full Text »|PDF »
Biventricular and atrial diastolic function assessment using conventional echocardiography and tissue-Doppler imaging in adults with Marfan syndrome.
A. Kiotsekoglou, J. C. Moggridge, B. H. Bijnens, V. Kapetanakis, F. Alpendurada, M. J. Mullen, S. Saha, D. K. Nassiri, J. Camm, G. R. Sutherland, et al. (2009)
Eur Heart J Cardiovasc Imaging
10, 947-955
|Abstract »|Full Text »|PDF »
The unravelling of primary myocardial impairment in Marfan syndrome by modern echocardiography.
A Kiotsekoglou, G R Sutherland, J C Moggridge, D K Nassiri, A J Camm, and A H Child (2009)
Heart
95, 1561-1566
|Abstract »|Full Text »|PDF »
Proteomic Analysis in Aortic Media of Patients With Marfan Syndrome Reveals Increased Activity of Calpain 2 in Aortic Aneurysms.
C. Pilop, F. Aregger, R. C. Gorman, R. Brunisholz, B. Gerrits, T. Schaffner, J. H. Gorman III, G. Matyas, T. Carrel, and B. M. Frey (2009)
Circulation
120, 983-991
|Abstract »|Full Text »|PDF »
To whom correspondence should be addressed. E-mail: 
